Nootropics Market to Grow with an Impressive CAGR During the Forecast Period
Increasing
demand for mind boosters is driving the growth in Global Nootropics Market in
the forecast period, 2022-2026.
According to TechSci Research report, “Global Nootropics
Market
By Type (Prescription v/s Over the Counter) By Product Type (Natural v/s
Synthetic) By Distribution Channel (Online v/s Offline) By Application (Memory
Enhancement, Mood & Depression, Attention & Focus, Longevity &
Anti-aging, Sleep & Recovery, Anxiety, Others) By Region, Competition
Forecast & Opportunities, 2026”, the global nootropics
market may potentially project an impressive growth in the forecast period,
2022-2026, with an impressive CAGR on the account of rising drug development
for the mental health issues like mood swings, depression, anxiety, and stress.
The rising instance of such mental illnesses is further enunciating the
growth of the global nootropics market in the upcoming five years. Rapidly
increasing research and drug development for the effects like enhancing
cognitive thinking, managing executive functions, enhancing psychological
parameters is further substantiating the growth of the global nootropics market
in the next five years. Moreover, rapidly surging demands from the student
population as an enhancer for concentrations and focus for their studies, to
improve their curricular activities, etc. is also supporting the growth of the
global nootropics market in the future five years of forecast until 2026.
Nootropics are the drugs, supplements and related
components that are expected to work efficiently in increasing and enhancing
brain activities like cognitive thinking, executive functioning of the brain,
higher memory retention, and creating senses of healthy motivation for the
individuals. Patients suffering from mood swings, depression, lack of attention
and focus, and sleep disorders are often prescribed nootropics for their
recovery. The substance is often associated with the term “smart drugs” for
their functions and effects they produce over the consumer.
In April 2019, Reckitt Benckiser, global producer
of popular consumer health, hygiene and home products, launched Neuriva, a
dietary supplement and holistic approach to support brain health. In September
2018, Koios Beverage Corp. announced the launch of two additional products its
existing line of beverages. The first product is a beverage infused with
cannabidiol (CBD), a cannabinoid derived from hemp plants, along with Koios'
proprietary nootropic stack.
Browse over XX
market data Figures spread through 110 Pages
and an in-depth TOC on "Global Nootropics Market"
https://www.techsciresearch.com/report/nootropics-market/7749.html
The global nootropics market is segmented by type,
product type, distribution channel, application channel, regional distribution,
and competitional analysis. Based on product type, the market is again divided
between natural and synthetic nootropics drugs. Natural nootropics drugs are
anticipated to hold the largest revenue shares and dominate the market segment
on the backbone of rising inclination of the consumers toward herbal and plant-based
nootropics.
Natural nootropics like caffeine, matcha tea, green
tea, beets, peanuts, eggs, liver, Brahmi, arctic root, turmeric, ginseng, pine
bark, etc. have grown popular in the recent years and their demands is rising among
the consumers owing to their growing popularity. Moreover, rising vegan
population is also influencing the growth of the natural nootropics and thereby
substantiating the growth of the global nootropics market in the next five
years.
Based on type, the market is further differentiated
between prescription and over the counter nootropics drugs. Prescription
nootropics drugs are anticipated to hold the largest revenue shares of the
market and assert its dominance over the market segment in the upcoming five
years on the account of rapidly increasing cases of depression, mood swings, anxiety,
and stress. The patients suffering from such mental health issues can control
their symptoms and these drugs help them to facilitate their thoughts. Also,
concerned legalities and ethical issues have made it essential for the
prescription to be produced to purchase the nootropics drugs thereby supporting
the growth of the global nootropics market in the next five years.
Holding the major shares of the global nootropics
market are Accelerated Intelligence Inc., AlternaScript LLC, Onnit Labs, Inc.,
Peak Nootropics LLC, Teva Pharmaceutical Industries Ltd., Purelife bioscience
Co., Ltd, SupNootropic bio co., Ltd, Cephalon, Inc., United Pharmacies (UK)
Ltd., Nootrobox Inc. (HVMN), among others. Market players are actively involved
in the research and technological development in the product developments. The
advanced technology has made it possible for the industry to provide excellent
services through nootropics drugs. Further advancement would aid the market
value and brand establishment in the future five years. New market players may
focus on the research and development to provide options that satisfies the
consumer demand as well as benefits the market players in building their brand
value. Other competitive strategies include mergers & acquisitions and new
product developments.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7749
Customers can also request for 10% free customization on this report.
“Asia Pacific is
anticipated to hold the largest revenue generating region in the future five
years. The trend of using nootropics for the enhancement of focus and concentration among the student’s
population is rapidly increasing and aiding the growth of the global nootropics
market in the upcoming five years. Moreover, higher awareness about effects of
nootropics among the population for preventive and cognitive health along with
the self-directed consumers is substantiating the growth of the market in future
five years. New market players are advised to focus on research and drug
development along with the affirmations from FDA and other legal bodies for the
sales of the nootropics drugs and thus substantiate their position in the
market,” said Mr. Karan Chechi, Research Director
with TechSci Research, a research based Global management consulting firm.
“Global Nootropics Market
By Type (Prescription v/s Over the Counter) By Product Type (Natural v/s
Synthetic) By Distribution Channel (Online v/s Offline) By Application (Memory
Enhancement, Mood & Depression, Attention & Focus, Longevity &
Anti-aging, Sleep & Recovery, Anxiety, Others) By Region, Competition
Forecast & Opportunities, 2026”, has evaluated the future growth potential
of global nootropics and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in global nootropics market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/